4//SEC Filing
Shoemaker Daniel D 4
Accession 0001209191-20-058492
CIK 0001434316other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 5:12 PM ET
Size
9.1 KB
Accession
0001209191-20-058492
Insider Transaction Report
Form 4
Shoemaker Daniel D
Chief Technology Officer
Transactions
- Sale
Common stock
2020-11-16$51.60/sh−5,287$272,825→ 107,872 total - Sale
Common stock
2020-11-16$52.40/sh−14,781$774,514→ 93,091 total - Sale
Common stock
2020-11-16$50.37/sh−4,932$248,407→ 113,159 total
Footnotes (4)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2020.
- [F2]Represents the weighted average sale price of the shares sold ranging from $49.91 to $50.90 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- [F3]Represents the weighted average sale price of the shares sold ranging from $50.95 to $51.93 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- [F4]Represents the weighted average sale price of the shares sold ranging from $51.96 to $52.88 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001586892
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 5:12 PM ET
- Size
- 9.1 KB